Stealth BioTherapeutics (MITO) Surges on FDA Rare Pediatric Disease Designation for Elamipretide

March 3, 2020 9:07 AM

Stealth BioTherapeutics (NASDAQ: MITO) surges 56 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found